atenolol has been researched along with sulfamethoxazole in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 10 (66.67) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Lee, Y; von Gunten, U | 1 |
| Jasper, JT; Sedlak, DL | 1 |
| Jeong, CB; Kim, BM; Lee, JS; Lee, YM; Leung, KM; Park, HG; Rhee, JS | 1 |
| Aga, DS; Ernstoff, AS; Love, NG; Moline, CJ; Stadler, LB; Su, L | 1 |
| Fér, M; Golovko, O; Grabic, R; Jakšík, O; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A; Vondráčková, L | 1 |
| Fér, M; Golovko, O; Grabic, R; Klement, A; Kočárek, M; Kodešová, R; Nikodem, A | 1 |
| Ding, T; Li, J; Wang, S; Yang, B | 1 |
15 other study(ies) available for atenolol and sulfamethoxazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Oxidative transformation of micropollutants during municipal wastewater treatment: comparison of kinetic aspects of selective (chlorine, chlorine dioxide, ferrate VI, and ozone) and non-selective oxidants (hydroxyl radical).
Topics: Ammonia; Atenolol; Bromides; Carbamazepine; Chlorine; Chlorine Compounds; Efficiency; Ethinyl Estradiol; Fresh Water; Hydroxyl Radical; Ibuprofen; Iron; Kinetics; Nitrites; Organic Chemicals; Oxidants; Oxidation-Reduction; Oxides; Ozone; Sulfamethoxazole; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Phototransformation of wastewater-derived trace organic contaminants in open-water unit process treatment wetlands.
Topics: Atenolol; Carbamazepine; Carbonates; Cimetidine; Dimethylnitrosamine; Diuron; Estradiol; Hydroxyl Radical; Models, Chemical; Photolysis; Propranolol; Sulfamethoxazole; Sunlight; Waste Disposal, Fluid; Wastewater; Water Pollutants, Chemical; Wetlands | 2013 |
Effect of pharmaceuticals exposure on acetylcholinesterase (AchE) activity and on the expression of AchE gene in the monogonont rotifer, Brachionus koreanus.
Topics: Acetaminophen; Acetylcholinesterase; Amino Acid Sequence; Analgesics, Non-Narcotic; Animals; Anti-Bacterial Agents; Atenolol; Base Sequence; Biocatalysis; Carbamazepine; Chlorpyrifos; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Gene Expression Regulation, Enzymologic; Helminth Proteins; Molecular Sequence Data; Oxytetracycline; Reverse Transcriptase Polymerase Chain Reaction; Rotifera; Sulfamethoxazole; Time Factors; Trimethoprim; Water Pollutants, Chemical; Xenobiotics | 2013 |
Effect of redox conditions on pharmaceutical loss during biological wastewater treatment using sequencing batch reactors.
Topics: Aerobiosis; Anaerobiosis; Atenolol; Biological Oxygen Demand Analysis; Bioreactors; Chromatography, High Pressure Liquid; Cyclohexanols; Desvenlafaxine Succinate; Nitrogen; Oxidation-Reduction; Oxygen; Pharmaceutical Preparations; Phenytoin; Sewage; Solid Phase Extraction; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Waste Disposal, Fluid; Water Pollutants, Chemical | 2015 |
Simultaneous sorption of four ionizable pharmaceuticals in different horizons of three soil types.
Topics: Adsorption; Atenolol; Carbamazepine; Ions; Pharmaceutical Preparations; Soil; Soil Pollutants; Sulfamethoxazole; Trimethoprim | 2016 |
Root uptake of atenolol, sulfamethoxazole and carbamazepine, and their transformation in three soils and four plants.
Topics: Atenolol; Carbamazepine; Plant Leaves; Plants; Raphanus; Soil; Soil Pollutants; Sulfamethoxazole | 2019 |
Biological removal of pharmaceuticals by Navicula sp. and biotransformation of bezafibrate.
Topics: Atenolol; Bezafibrate; Biodegradation, Environmental; Carbamazepine; Diatoms; Fresh Water; Ibuprofen; Inactivation, Metabolic; Naproxen; Pharmaceutical Preparations; Sulfamethoxazole; Water Pollutants, Chemical | 2020 |